Inactive Instrument
Five Prime Therapeutics, Inc. Share Price
Stocks
FPRX
US33830X1046
Biotechnology & Medical Research
| 1 day | +0.03% |
| Manager | Title | Age | Since |
|---|---|---|---|
James Bradner
CEO | Chief Executive Officer | 53 | - |
Peter Griffith
DFI | Director of Finance/CFO | 67 | - |
Jonathan Graham
LAW | General Counsel | 65 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/04/21 | Issuer sale | Director | 80,000 | 0.1718% | ||
| 16/04/21 | Issuer sale | Director | 72,500 | 0.1557% | ||
| 16/04/21 | Issuer sale | Director | 80,000 | 0.1718% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | +0.16% | - | - | 174.05Cr | |
| -1.82% | +5.03% | +56.71% | +66.69% | 5.73TCr | |
| -0.27% | +5.74% | +40.26% | +80.17% | 5.5TCr | |
| -2.05% | -2.14% | +2.93% | +413.38% | 2.32TCr | |
| +1.97% | -1.16% | -19.24% | -13.25% | 2.26TCr | |
| -1.13% | +4.54% | +22.73% | -8.06% | 2.05TCr | |
| +1.57% | +2.09% | +28.01% | -27.56% | 1.76TCr | |
| -0.10% | +5.57% | +38.63% | +565.16% | 1.57TCr | |
| +5.29% | 0.00% | +185.09% | +332.66% | 1.45TCr | |
| +0.79% | +0.50% | +25.73% | +184.74% | 1.39TCr | |
| Average | +0.50% | +1.62% | +42.32% | +177.10% | 2.67TCr | |
| Weighted average by Cap. | -0.06% | +1.93% | +40.37% | +137.85% |
Employees
51
